Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPVG.L Regulatory News (PVG)

  • There is currently no data for PVG

Blocklisting Interim Review

6 Dec 2013 17:46

RNS Number : 9748U
Ark Therapeutics Group PLC
06 December 2013
 



BLOCK LISTING SIX MONTHLY RETURN

 

Date: 6 December 2013

 

Name of applicant:

Ark Therapeutics Group plc

Name of scheme:

Ark Therapeutics Group Unapproved Share Option Scheme

Period of return:

From:

03/06/2013

To:

02/12/2013

Balance of unallotted securities under scheme from previous return:

2,271,252

Plus: The amount by which the block scheme has been increased since the date of the last return (if any increase has been applied for):

NIL

Less: Number of securities issued/allotted under scheme during period:

NIL

Equals: Balance under scheme not yet issued/allotted at end of period:

2,271,252

 

Name of applicant:

Ark Therapeutics Group plc

Name of scheme:

Ark Therapeutics Group Enterprise Management Incentive Share Option Plan

Period of return:

From:

03/06/2013

To:

02/12/2013

Balance of unallotted securities under scheme from previous return:

939,433

Plus: The amount by which the block scheme has been increased since the date of the last return (if any increase has been applied for):

NIL

Less: Number of securities issued/allotted under scheme during period:

NIL

Equals: Balance under scheme not yet issued/allotted at end of period:

939,433

 

Name of applicant:

Ark Therapeutics Group plc

Name of scheme:

Ark Therapeutics Group 2005 Long Term Incentive Plan

Period of return:

From:

03/06/2013

To:

02/12/2013

Balance of unallotted securities under scheme from previous return:

683,200

Plus: The amount by which the block scheme has been increased since the date of the last return (if any increase has been applied for):

NIL

Less: Number of securities issued/allotted under scheme during period:

NIL

Equals: Balance under scheme not yet issued/allotted at end of period:

683,200

 

Name of applicant:

Ark Therapeutics Group plc

Name of scheme:

Ark Therapeutics Group Approved Share Option Plan

Period of return:

From:

03/06/2013

To:

02/12/2013

Balance of unallotted securities under scheme from previous return:

1,000,000

Plus: The amount by which the block scheme has been increased since the date of the last return (if any increase has been applied for):

NIL

Less: Number of securities issued/allotted under scheme during period:

NIL

Equals: Balance under scheme not yet issued/allotted at end of period:

1,000,000

 

 

Name of contact:

Sue Steven, Company Secretary

Telephone number of contact:

0207 002 1005

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BLRDMMGZNVDGFZM
Date   Source Headline
10th Mar 20101:21 pmRNSEPT Disclosure
10th Mar 201011:52 amRNSEPT Disclosure
10th Mar 20107:00 amRNSFinal Results
9th Mar 20107:00 amRNSResearch Update
8th Mar 20105:34 pmRNSHolding(s) in Company
23rd Feb 20107:00 amRNSResearch Update
19th Feb 20107:00 amRNSRe Agreement
16th Feb 20104:40 pmRNSSecond Price Monitoring Extn
16th Feb 20104:35 pmRNSPrice Monitoring Extension
11th Feb 201011:37 amRNSDirector/PDMR Shareholding
5th Feb 20104:35 pmRNSPrice Monitoring Extension
29th Jan 20103:23 pmRNSTotal Voting Rights
28th Jan 201011:05 amRNSNotice of Results
28th Jan 20107:02 amRNSResearch Update
28th Jan 20107:00 amRNSResearch Update
20th Jan 20103:51 pmRNSEmployee Benefit Trust
5th Jan 20107:00 amRNSArk files for re-examination of Cerepro
22nd Dec 20094:41 pmRNSSecond Price Monitoring Extn
22nd Dec 20094:35 pmRNSPrice Monitoring Extension
18th Dec 200911:56 amRNSEMEA recommendation on Cerepro
15th Dec 20092:29 pmRNSHolding(s) in Company
3rd Dec 20092:41 pmRNSBlocklisting Interim Review
3rd Dec 20092:35 pmRNSHolding(s) in Company
24th Nov 20094:04 pmRNSHolding(s) in Company
11th Nov 20097:00 amRNSInterim Management Statement
14th Oct 20097:00 amRNSResearch Update
2nd Oct 200911:04 amRNSHolding(s) in Company
30th Sep 200910:51 amRNSHolding(s) in Company
29th Sep 20094:32 pmRNSHolding(s) in Company
4th Sep 20097:00 amRNSResearch Update
1st Sep 200912:08 pmRNSDirector/PDMR Shareholding
26th Aug 20097:00 amRNSResearch Update
26th Aug 20097:00 amRNSHalf Yearly Report
13th Jul 20097:00 amRNSArk launches Kerraglove woundcare device
1st Jul 20097:00 amRNSRe Agreement
26th Jun 20092:15 pmRNSHolding(s) in Company
24th Jun 20097:00 amRNSManufacturing Update
17th Jun 20097:00 amRNSRe Agreement
3rd Jun 200911:47 amRNSBlocklisting Interim Review
21st May 20097:00 amRNSTrinam Phase III Study Enrols First Patient
18th May 20097:00 amRNSInterim Management Statement
15th May 20097:00 amRNSCerepro Named Patient Supply approved in Finland
13th May 20094:41 pmRNSSecond Price Monitoring Extn
13th May 20094:35 pmRNSPrice Monitoring Extension
12th May 20097:00 amRNSDirector/PDMR Shareholding
6th May 20094:40 pmRNSSecond Price Monitoring Extn
6th May 20094:35 pmRNSPrice Monitoring Extension
5th May 20097:00 amRNSTrinam(R) Awarded Fast Track Status by FDA
30th Apr 20094:01 pmRNSTotal Voting Rights
30th Apr 200912:00 pmRNSPrestigious European Award

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.